Interferon gamma release assays for the diagnosis of latent TB infection in HIV-infected individuals in a low TB burden country.
Interferon gamma release assays (IGRAs) are used to diagnose latent tuberculosis infection. Two IGRAs are commercially available: the Quantiferon TB Gold In Tube (QFT-IT) and the T-SPOT.TB. There is debate as to which test to use in HIV+ individuals. Previous publications from high TB burden countri...
Main Authors: | Clíona Ní Cheallaigh, Ian Fitzgerald, Jacinta Grace, Gurmit Jagjit Singh, Nahla El-Eraki, Noel Gibbons, Joseph Keane, Thomas R Rogers, Susan Clarke, Colm Bergin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3559731?pdf=render |
Similar Items
-
TB or Not TB: Treatment of Latent Tuberculosis Infection in Harlem, New York
by: Hirsch-Moverman, Yael
Published: (2011) -
Controlling latent TB tuberculosis infection in high-burden countries: A neglected strategy to end TB.
by: Gavin J Churchyard, et al.
Published: (2019-04-01) -
Latent TB Infection among Healthcare Workers
by: Pei-Ling Hung, et al.
Published: (2006) -
The Change of Inferferon-gamma responses between Latent TB Infection and Active TB Disease
by: Chen, Shemei, et al.
Published: (2011) -
The use of anti-tuberculosis therapy for latent TB infection
by: Justin T Denholm, et al.
Published: (2010-07-01)